Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs morphine PCIA after lower extremity fracture surgery
ChiCTR2600128912Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine and morphine in postoperative pain and Rebound pain (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Incidence of rebound pain after peripheral nerve block. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
tegileridinemorphine
03
Conditions
postoperative painRebound pain
Beyond the preview
Go deeper on ChiCTR2600128912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128912.